EMPOWERING ALEXION SCIENTISTS THROUGH INTUITIVE DATA APPLICATIONS Alexion Pharmaceuticals, Inc. tackles rare diseases using biologic therapeutics. These transform the lives of many patients affected by devastating conditions such as generalized Myasthenia Gravis (gMG) and Hypophosphatasia (HPP). Development-stage research requires harmonization of heterogeneous data and constant refinement of the data curation process. Through use of the Tetra Data Platform (TDP), Alexion can more easily access protein purification data FPLC so that scientists can directly probe, test, and identify their best protein purification strategy with only a few clicks. Alexion can execute a digital pharma strategy and AI/ML- powered drug discovery through data harmonization in the cloud. SUCCESS METRICS

Join for free to read